Issue 6/2023
Content (40 Articles)
Complementary and alternative medicine application in cancer patients in Iran
Nazi Nejat, Amir Rahbarian, Fatemeh Mehrabi, Fatemeh Rafiei
Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma
S. M. Adnan Ali, Yumna Adnan, Saleema Mehboob Ali, Zubair Ahmad, Tabish Chawla, Hasnain Ahmed Farooqui
Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
Yunteng Wu, Dongliang Wei, Guoxin Ren, Wei Guo
Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia
Yuqiu Ge, Bin Xu, Hongzhou Cai, Wentao Jing, Qiong Ouyang, Qinbo Yuan, Xu Li, Yuanming Fan, Yang Shen, Qianqian Shi, Qiangdong Wang, Li Cui, Xiaojian Yin, Gaoxiang Ma
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era
Yi Chen, Luting Luo, Lushan Chen, Xiaoyun Zheng, Xiaozhu Yang, Zhihong Zheng, Jing Zheng, Tingbo Liu, Ting Yang, Jianda Hu
Heterozygous germline FLCN mutation in Birt–Hogg–Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report
Jun Li, Fan Liu, Xuguang Liu, Yu Hu, Zheng Liu, Yaqi Shen, Jie Wan
Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis
Zhuochen Cai, Dongni Chen, Wenze Qiu, Chixiong Liang, Yingying Huang, Jiayu Zhou, Zejiang Zhan, Yanqun Xiang, Xiang Guo, Xing Lv
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
Timothy J. Brown, Ronac Mamtani, Phyllis A. Gimotty, Thomas B. Karasic, Yu-Xiao Yang
Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance
Jung Sun Kim, Soyeon Kim, Jaemoon Koh, Miso Kim, Bhumsuk Keam, Tae Min Kim, Bertil Lindmark, Dong-Wan Kim
Lymph node distribution in patients with remnant gastric cancer
Alexandre Augusto Ferreira Bafutto, Osvaldo Antonio Prado Castro, Daniel Kendi Fukuhara, Wilson Rodrigues de Freitas Jr, Caio de Carvalho Zanon, Laura Lopes Claro, Marineide Carvalho, Elias Jirjoss Ilias, Carlos Alberto Malheiros, Paulo Kassab
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Muhammad Awidi, Brendan Connell, Delaney Johnson, Isabel Craven, Rojer Ranjit, Brigitte Gil, Natalie Dal’Bo, Lewena Maher, Seanna Reilly Daves, Stephanie McDonald, Krishna S. Gunturu
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study
Lan Zhang, Xingnong Ye, Shuna Luo, Xiaofei Xu, Shengjie Wang, Keyi Jin, Yan Zheng, Xiaoqiong Zhu, Dan Chen, Jie Jin, Jian Huang
Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis
Zhujiang Dai, Xiang Peng, Yuegui Guo, Xia Shen, Wenjun Ding, Jihong Fu, Zhonglin Liang, Jinglue Song
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
Damian J. Ralser, Mateja Condic, Niklas Klümper, Jörg Ellinger, Christian Staerk, Eva K. Egger, Glen Kristiansen, Alexander Mustea, Thore Thiesler
Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma
Shin Ishihara, Takeshi Iwasaki, Kenichi Kohashi, Kengo Kawaguchi, Yu Toda, Toshifumi Fujiwara, Nokitaka Setsu, Makoto Endo, Yoshihiro Matsumoto, Yasuharu Nakashima, Yoshinao Oda
Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model
Mojgan Ghaedi, Forough Golsaz-Shirazi, Tannaz Bahadori, Jalal Khoshnoodi, Sahar Mortezagholi, Mahmood Jeddi-Tehrani, Mohammad Mehdi Amiri, Fazel Shokri
Whole-exome sequencing of Indian prostate cancer reveals a novel therapeutic target: POLQ
Febina Ravindran, Anika Jain, Sagar Desai, Navjoth Menon, Kriti Srivastava, Pushpinder Singh Bawa, K. Sateesh, N. Srivatsa, S. K. Raghunath, Subhashini Srinivasan, Bibha Choudhary
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
Klara Dorman, Miriam Gerckens, Stephan Kruger, Kimberly Krueger, Zsuzsanna Mayer, Alexander Rupp, Danmei Zhang, Lena Weiss, C. Benedikt Westphalen, Michael Haas, Michael Guenther, Steffen Ormanns, Frank Klawonn, Jens Werner, Michael von Bergwelt-Baildon, Volker Heinemann, Stefan Boeck, Stefan Holdenrieder
Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study
Tae Hata, Chikara Sakaguchi, Keita Hirano, Hiroshi Kobe, Masaki Ishida, Takayuki Nakano, Yusuke Tachibana, Nobuyo Tamiya, Shinsuke Shiotsu, Takayuki Takeda, Tadaaki Yamada, Toshihide Yokoyama, Michiko Tsuchiya, Yukio Nagasaka
The prognostic role of PSMD14 in head and neck squamous cell carcinoma
Julia Schnoell, Alexandra Scheiflinger, Sega Al-Gboore, Lorenz Kadletz-Wanke, Lukas Kenner, Gregor Heiduschka, Bernhard J. Jank
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
Jinbin Chen, Peiyao Xiong, Man Nie, Yangxun Pan, Juncheng Wang, Dandan Hu, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Li Xu
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
Fabian B. T. Kraus, Nicole E. Topalov, E. Deuster, I. Hysenaj, D. Mayr, A. Chelariu-Raicu, S. Beyer, T. Kolben, A. Burges, S. Mahner, F. Trillsch, U. Jeschke, B. Czogalla
Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma
Cristian Urla, Matias Julian Stagno, Jörg Fuchs, Steven Walter Warmann, Evi Schmid
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
Sofya Marchenko, Iris Piwonski, Inga Hoffmann, Bruno Valentin Sinn, Catarina Alisa Kunze, Nanna Monjé, Jonathan Pohl, Hagen Kulbe, Wolfgang Daniel Schmitt, Sylvia Darb-Esfahani, Elena Ioana Braicu, Ann-Christin von Brünneck, Jalid Sehouli, Carsten Denkert, David Horst, Korinna Jöhrens, Eliane Tabea Taube
Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy
Arefeh Saeedian, Afsaneh Maddah Safaei, Amirali Azimi, Kasra Kolahdouzan, Fatemeh-sadat Tabatabaei, Ebrahim Esmati
Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma
Xin Li, Xinyu Su, Chen Yan, Yuanyuan Ma, Heng Li, Jianhong Xia, Hongliang Li, Qian Jiang, Liqing Zhou, Zhengyun Zou
Chronological development of in-patient oncology in times of COVID-19: a retrospective analysis of hospitalized oncology and COVID-19 patients of a German University Hospital
Sebastian Griewing, Uwe Wagner, Michael Lingenfelder, Rebecca Fischer, Matthias Kalder
TKIs beyond immunotherapy predict improved survival in advanced HCC
Samantha Armstrong, Tina Roy, Bhavana Singh, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C. Jha, Marion L. Hartley, Aiwu Ruth He
Combined diagnosis of multiparametric MRI-based deep learning models facilitates differentiating triple-negative breast cancer from fibroadenoma magnetic resonance BI-RADS 4 lesions
Hao-lin Yin, Yu Jiang, Zihan Xu, Hui-hui Jia, Guang-wu Lin
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects
Guangwen Liu, Jinling Xue, Yanli Wang, Zhengzhi Liu, Xue Li, Dongmei Qu, Zhengjie Su, Kaibo Xu, Xinyao Qu, Zhaojuan Qu, Linlin Sun, Mingming Cao, Ying Wang, Xuesong Chen, Jing Yu, Lang Liu, Qiaohuan Deng, Yicheng Zhao, Lixiu Zhang, Haimiao Yang
Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects
Xin Ouyang, Chuanming Xu
Bioenergy therapies as a complementary treatment: a systematic review to evaluate the efficacy of bioenergy therapies in relieving treatment toxicities in patients with cancer
M. Hauptmann, S. Kutschan, J. Hübner, J. Dörfler
BDNF and its signaling in cancer
Mohammad Malekan, Sasan Salehi Nezamabadi, Elham Samami, Mehdi Mohebalizadeh, Amene Saghazadeh, Nima Rezaei
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion
Arne Bartol, Katrin Dressler, Peter Kaskel, Christiane Landsberg, Cornelia Lechner, Marco Petschulies
Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria
Thomas Haverkamp, Olivia Bronisch, Thomas Knösel, Carolin Mogler, Wilko Weichert, Thomas Stauch, Claudia Schmid, Claudia Rummeny, Maria K. Beykirch, Petro E. Petrides
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, Marta Fudalej, Andrzej Deptała, Anna M. Badowska-Kozakiewicz
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
Aleksander Ślusarczyk, Piotr Zapała, Łukasz Zapała, Piotr Radziszewski
Progress in the treatment of urethral adenocarcinoma
Jiamin Guo, Xiuping Liang, Yichen Zheng, Ji Ma
The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Mingguang Ju, Ziming Gao, Xiaofang Liu, Heng Zhou, Ruiying Wang, Chen Zheng, Daosong Dong, Zhi Zhu, Kai Li
Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?
Konstantinos Drougkas, Konstantinos Karampinos, Ioannis Karavolias, Ioannis-Alexios Koumprentziotis, Ioanna Ploumaki, Efthymios Triantafyllou, Ioannis Trontzas, Elias Kotteas